Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Nov:52:253-260.
doi: 10.1016/j.intimp.2017.08.028. Epub 2017 Oct 12.

Interferon-omega: Current status in clinical applications

Shi-Fang Li  1 , Fu-Rong Zhao  2 , Jun-Jun Shao  1 , Yin-Li Xie  1 , Hui-Yun Chang  3 , Yong-Guang Zhang  1
Affiliations
Review

Interferon-omega: Current status in clinical applications

Shi-Fang Li et al. Int Immunopharmacol. 2017 Nov.

Abstract

Since 1985, interferon (IFN)-ω, a type I IFN, has been identified in many animals, but not canines and mice. It has been demonstrated to have antiviral, anti-proliferation, and antitumor activities that are similar to those of IFN-α. To date, IFN-ω has been explored as a treatment option for some diseases or viral infections in humans and other animals. Studies have revealed that human IFN-ω displays antitumor activities in some models of human cancer cells and that it can be used to diagnose some diseases. While recombinant feline IFN-ω has been licensed in several countries for treating canine parvovirus, feline leukemia virus, and feline immunodeficiency virus infections, it also exhibits a certain efficacy when used to treat other viral infections or diseases. This review examines the known biological activity of IFN-ω and its clinical applications. We expect that the information provided in this review will stimulate further studies of IFN-ω as a therapeutic agent.

Keywords: Application; Biological activity; Interferon omega; Type I IFN.

PubMed Disclaimer

References

    1. Isaacs A., Lindenmann J. Virus interference. I, the interferon. J. Immunol. 2015;195:1911–1920. - PubMed
    1. Tian L., Zhao P., Ma B., Guo G., Sun Y., Xing M. Cloning, expression and antiviral bioactivity of red-crowned crane interferon-alpha. Gene. 2014;544:49–55. - PubMed
    1. Cheng G., Chen W., Li Z. Characterization of the porcine alpha interferon multigene family. Gene. 2006;382:28–38. - PubMed
    1. Pitha P.M., Kunzi M.S. Interferon: The 50th Anniversary. Vol. 316. 2007. Type I interferon: the ever unfolding story; pp. 41–70. - PubMed
    1. Roberts R.M., Liu L.M., Alexenko A. New and atypical families of type I interferons in mammals: comparative functions, structures, and evolutionary relationships. Prog. Nucleic Acid Res. Mol. Biol. 1997;56:287–325. - PubMed